Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BALAXI PHARMA vs MEWAT ZINC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BALAXI PHARMA MEWAT ZINC BALAXI PHARMA/
MEWAT ZINC
 
P/E (TTM) x 12.2 64.2 19.0% View Chart
P/BV x 2.2 13.4 16.4% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 BALAXI PHARMA   MEWAT ZINC
EQUITY SHARE DATA
    BALAXI PHARMA
Mar-24
MEWAT ZINC
Mar-24
BALAXI PHARMA/
MEWAT ZINC
5-Yr Chart
Click to enlarge
High Rs686201 342.0%   
Low Rs40029 1,387.8%   
Sales per share (Unadj.) Rs221.412.7 1,737.7%  
Earnings per share (Unadj.) Rs-2.21.6 -139.0%  
Cash flow per share (Unadj.) Rs-0.31.6 -16.1%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs181.311.6 1,569.2%  
Shares outstanding (eoy) m10.9010.00 109.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.59.0 27.2%   
Avg P/E ratio x-248.072.8 -340.5%  
P/CF ratio (eoy) x-2,051.669.7 -2,941.7%  
Price / Book Value ratio x3.09.9 30.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,9191,148 515.8%   
No. of employees `000NANA-   
Total wages/salary Rs m28013 2,228.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m2,413127 1,894.1%  
Other income Rs m64 179.3%   
Total revenues Rs m2,419131 1,848.0%   
Gross profit Rs m6221 294.5%  
Depreciation Rs m211 2,997.1%   
Interest Rs m280 6,146.7%   
Profit before tax Rs m2024 85.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m448 562.2%   
Profit after tax Rs m-2416 -151.5%  
Gross profit margin %2.616.7 15.5%  
Effective tax rate %218.533.2 658.1%   
Net profit margin %-1.012.4 -8.0%  
BALANCE SHEET DATA
Current assets Rs m2,102271 775.1%   
Current liabilities Rs m542161 337.1%   
Net working cap to sales %64.686.6 74.6%  
Current ratio x3.91.7 229.9%  
Inventory Days Days80-  
Debtors Days Days8431,331 63.3%  
Net fixed assets Rs m4824 11,073.8%   
Share capital Rs m109100 109.0%   
"Free" reserves Rs m1,86716 12,029.2%   
Net worth Rs m1,976116 1,710.4%   
Long term debt Rs m00-   
Total assets Rs m2,583276 937.7%  
Interest coverage x1.753.4 3.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.5 202.0%   
Return on assets %0.15.9 2.5%  
Return on equity %-1.213.6 -8.9%  
Return on capital %2.420.8 11.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6480-   
Fx outflow Rs m1937 51.0%   
Net fx Rs m629-37 -1,708.6%   
CASH FLOW
From Operations Rs m49-2 -2,433.0%  
From Investments Rs m-10-106 9.8%  
From Financial Activity Rs m303118 256.5%  
Net Cashflow Rs m34110 3,549.4%  

Share Holding

Indian Promoters % 66.0 64.9 101.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 16.5 0.0 -  
FIIs % 16.5 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 34.0 35.1 96.8%  
Shareholders   7,863 2,044 384.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BALAXI PHARMA With:   ADANI ENTERPRISES    REDINGTON    MMTC    SIRCA PAINTS INDIA    UNIPHOS ENT    


More on BALAXI PHARMA vs MEWAT ZINC

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BALAXI PHARMA vs MEWAT ZINC Share Price Performance

Period BALAXI PHARMA MEWAT ZINC S&P BSE HEALTHCARE
1-Day 4.16% 3.75% 0.85%
1-Month -14.20% -1.40% -0.62%
1-Year -80.92% 342.73% 43.07%
3-Year CAGR -49.78% 125.93% 20.20%
5-Year CAGR -33.85% 64.42% 26.15%

* Compound Annual Growth Rate

Here are more details on the BALAXI PHARMA share price and the MEWAT ZINC share price.

Moving on to shareholding structures...

The promoters of BALAXI PHARMA hold a 66.0% stake in the company. In case of MEWAT ZINC the stake stands at 64.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BALAXI PHARMA and the shareholding pattern of MEWAT ZINC.

Finally, a word on dividends...

In the most recent financial year, BALAXI PHARMA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

MEWAT ZINC paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of BALAXI PHARMA, and the dividend history of MEWAT ZINC.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today(Pre-Open)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.